C181 - Treatment of Pediatric Multiple Sclerosis in the Current Era
| Event Time: | Wednesday May 8, 2019 1:00 pm to 3:00 pm |
| Topic(s): | Child Neurology and Developmental Neurology, MS and CNS Inflammatory Disease |
| Director(s): | Brenda Banwell MD, FAAN |
| Description: | This program will focus on recent advances in the care of children and teens with multiple sclerosis. Faculty will first review the 2017 diagnostric criteria for MS, outlining how these criteria apply in the pediatric MS context. The emerging recognition of myelin oligodendrocyte glycoprotein (MOG) antibodies in identifying pediatric patients with a non-MS clinical course will be highlighted. Following discussion regarding accurate diagnosis, faculty will then focus on treatment. The recent PARADIGMS trial, the first large-scale randomized clinical trial in pediatric MS, will be reviewed. An overview of ongoing clinical trials will be presented. An approach to clinical care will be demonstrated, including dosing and safety monitoring considerations. Finally, faculty will synthesize the current treatment landscape with discussion centered on strategies for early, effective, and evidence-based care for pediatric MS. |
| Completion Message: | Attendees should feel competent in the approach to diagnosis of MS in children; will be provided with strategies to investigate disorders considered in the differential, in order to meet the requirement of "excluding other diagnoses" prior to conferring the diagnosis of MS; be able to discuss up-to-date information regarding currently available therapeutic agents for pediatric MS, including dosing and safety monitoring; and be informed regarding upcoming clinical trials for pediatric MS. |
| CME Credits: | 2 |
| Core Competencies: | Patient Care, Medical Knowledge, Practice-Based Learning and Improvement |
| Start/End Time | Title | Faculty |
|---|---|---|
| 1:00 PM - 1:05 PM | Introduction and Welcome | Brenda Banwell MD, FAAN |
| 1:05 PM - 1:45 PM | Diagnosis of Pediatric MS: Considerations of Treatment Selection | Brenda Banwell MD, FAAN |
| 1:45 PM - 2:15 PM | PARADIGMS Trial: Implications for Pediatric MS | Tanuja Chitnis MD, FAAN |
| 2:15 PM - 2:45 PM | Upcoming Clinical Trials in Pediatric MS | Emmanuelle Waubant MD, PhD, FAAN |
| 2:45 PM - 3:00 PM | Audience Discussion | Brenda Banwell MD, FAAN, Tanuja Chitnis MD, FAAN, Emmanuelle Waubant MD, PhD, FAAN |
| Speaker | Disclosure |
|---|---|
| Brenda Banwell, MD, FAAN | Dr. Banwell has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Novartis. |
| Tanuja Chitnis, MD, FAAN | Dr. Chitnis has received personal compensation for advisory boards/consulting with F. Hoffman-La Roche, Biogen and Novartis. Dr Chitnis has received research support from Biogen, Merck Serono, Verily and Novartis. |
| Emmanuelle Waubant, MD, PhD, FAAN | Dr. Waubant has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with AAN for Frontiers in neurology talk, The Corpus for talks, compensation for editorial work for Annals of Clinical and Translational Neurology and MS and Related Disorders. Site PI for clinical trials with Roche, Biogen Idec and Novartis |
Ready to register for the 2019 AAN Annual Meeting?
Related Courses
| 7:00 AM-9:00 AM |
|---|
|
C4 -
Pediatric Neuro-ophthalmology Update
Christopher Glisson DO, FAAN |
| 9:30 AM-11:30 AM |
|
C14 -
Child Neurology: Headache
Amy Gelfand MD |
|
C19 -
Multiple Sclerosis Overview I: Clinical Pearls
Mary Willis MD |
| 1:30 PM-3:30 PM |
|
C29 -
Multiple Sclerosis Overview II: Clinical Advances
Scott Newsome DO, FAAN |
| 7:00 AM-9:00 AM |
|---|
|
C40 -
Child Neurology: Stroke
Lori Billinghurst MD |
|
C44 -
Multiple Sclerosis Therapy: Symptom Management
Andrew Solomon MD |
| 9:15 AM-12:00 PM |
|
Presidential Plenary Session
Natalia Rost MD, MPH, FAAN, FAHA |
| 11:30 AM-6:30 PM |
|
P1 -
Poster Session 1
|
| 1:00 PM-3:00 PM |
|
C49 -
Neurology Update I: Multiple Sclerosis, Sleep, and Neuromuscular Disease
Ralph Jozefowicz MD, FAAN, Adam Quick MD |
|
C56 -
Multiple Sclerosis Therapy: Disease-modifying Treatment I
Scott Newsome DO, FAAN |
|
S6 -
MS and CNS Inflammatory Disease: Clinical Considerations I
|
| 3:30 PM-5:30 PM |
|
C73 -
Multiple Sclerosis Therapy: Disease-modifying Treatment II
John Rose MD, FAAN |
|
N1 -
Neuroscience in the Clinic: Child Neurology: Emerging Understanding of the Epilepsy-Movement Disorder Spectrum Across the Lifespan
Deborah Hall MD, PhD, FAAN, Erika Augustine MD, FAAN |
| 7:00 AM-9:00 AM |
|---|
|
C82 -
Stroke in Young Adults and Women
Aneesh Singhal MD, FAAN |
|
C86 -
Neuromyelitis Optica Spectrum Disorders
Dean Wingerchuk MD, FAAN |
| 9:15 AM-12:00 PM |
|
Contemporary Clinical Issues Plenary Session
Randolph Marshall MD, FAAN |
| 11:30 AM-6:30 PM |
|
P2 -
Poster Session 2
|
| 1:00 PM-3:00 PM |
|
C92 -
Autism Spectrum Disorders What We Know and Where We Are Going
Rujuta Wilson MD |
|
C100 -
Esclerosis Múltiple y Otras Enfermedades Inflamatorias Desmielinizantes y Autoinmunes del Sistema Nervioso Central (MS and Other Demyelinating Inflammatory and Autoimmune Central Nervous System Disorders)
Lilyana Amezcua MD, FAAN |
|
S12 -
Progressive Multiple Sclerosis
|
| 3:00 PM-3:45 PM |
|
Child Neurology for Trainees
Rana Said MD, FAAN |
| 3:30 PM-5:30 PM |
|
S19 -
Child Neurology: Updates in Autism, Migraine, MS, and Stroke
|
| 7:00 AM-9:00 AM |
|---|
|
C123 -
Child Neurology: Genetic and Metabolic Testing in Pediatric Epilepsy
James Riviello MD |
|
C130 -
Diagnostic Pearls in Myelitis: a Case-based Approach
Eoin Flanagan MBBCh |
| 9:15 AM-11:30 AM |
|
Clinical Trials Plenary Session
Deborah Hall MD, PhD, FAAN, Holly Hinson MD, MCR, FAAN |
| 11:30 AM-6:30 PM |
|
P3 -
Poster Session 3
|
| 1:00 PM-3:00 PM |
|
N3 -
Neuroscience in the Clinic: Stem Cells
Paul George MD, PhD, MSE, Antonio Omuro MD |
|
S25 -
Child Neurology: Spinal Muscular Atrophy: Treatments and Outcomes
|
|
S26 -
MS and CNS Inflammatory Disease: Clinical Considerations II
|
| 3:30 PM-5:30 PM |
|
C161 -
Child Neurology: Metabolic
Marc Patterson MD, FAAN, FRACP |
|
S31 -
MS and CNS Inflammatory Disease: Imaging
|
| 7:00 AM-9:00 AM |
|---|
|
C171 -
Child Neurology: Neuromuscular/Autoimmune Neurology
Anne Connolly MD, FAAN |
| 9:15 AM-11:30 AM |
|
Frontiers in Neuroscience Plenary Session
Paul George MD, PhD, MSE |
| 11:30 AM-6:30 PM |
|
P4 -
Poster Session 4
|
| 1:00 PM-3:00 PM |
|
S37 -
MS Biomarkers
|
| 3:30 PM-5:30 PM |
|
C198 -
Integrating Sleep Medicine Concepts into Your Child Neurology Practice
Suresh Kotagal MD, FAAN |
|
Presentation of the John Dystel Prize for Multiple Sclerosis Research
|
| 3:45 PM-4:15 PM |
|
Update on the Complementary Therapies for MS: An Evidence-based Review
Vijayshree Yadav MD, FAAN |
| 7:00 AM-9:00 AM |
|---|
|
C214 -
Child Neurology: A Case-based Approach
Elaine Wirrell MD, FAAN |
| 11:30 AM-6:30 PM |
|
P5 -
Poster Session 5
|
| 12:00 PM-12:45 PM |
|
A "How to and Why" of the Shared Medical Appointments: A Way to Meet the Needs of the Patient and Provider While Maximizing Clinical Time
Mary Rensel MD, FAAN, Nancy Isenberg MD, MPH, FAAN |
| 1:00 PM-3:00 PM |
|
S49 -
MS Epidemiology and Risk Stratification
|
| 3:30 PM-5:30 PM |
|
S51 -
Child Neurology: Bench to Bedside: Progress in Treating Genetic Disorders
|
|
S55 -
MS Basic Science
|
| 7:00 AM-9:00 AM |
|---|
|
C248 -
Multiple Sclerosis in the Trenches: Controversy and Consensus in Clinical Decision-Making
Aaron Miller MD, FAAN |
| 9:15 AM-11:30 AM |
|
Neurology Year in Review Plenary Session
Martinson Arnan MD |
| 11:45 AM-12:45 PM |
|
Friday Grand Finale: Neuroimaging
|
| 1:00 PM-3:00 PM |
|
S56 -
MS Trials and Treatment
|
| 3:30 PM-4:30 PM |
|
C254 -
Education Blitz: Child Neurology: Concussion
Meeryo Choe MD |
|
C258 -
Education Blitz: Multiple Sclerosis
Stephen Krieger MD, FAAN |